BOC vs GASS
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Boston Omaha Corporation (BOC) exhibits severe financial distress signals, underscored by a Piotroski F-Score of 2/9, indicating weak operational and financial health. The company reports negative profitability across all key metrics—ROE, ROA, and profit margin—while its earnings have consistently missed estimates, with an average surprise of -383.33% over the last four quarters. Despite a low Price/Book ratio of 0.72 and a relatively healthy current ratio of 2.07, the absence of a meaningful Altman Z-Score and persistent losses raise serious concerns about long-term solvency. The stock trades at a 52-week discount but remains underperforming, with a 5-year decline of 66%, reflecting deep market skepticism. The lack of analyst coverage and neutral insider activity further diminish conviction.
GASS exhibits exceptional financial health with a perfect Piotroski F-Score of 9/9 and a debt-free balance sheet (Debt/Equity 0.00). The stock is severely undervalued, trading at $9.48 against a Graham Number of $26.56 and an Intrinsic Value of $22.55. While revenue growth is currently negative (-9.40%), the company maintains high profit margins (35.02%) and a consistent track record of earnings beats. The primary headwinds are technical bearishness and low insider sentiment, but the fundamental value proposition is compelling.
Compare Another Pair
Related Comparisons
BOC vs GASS: Head-to-Head Comparison
This page compares Boston Omaha Corporation (BOC) and StealthGas Inc. (GASS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.